Psychedelics Industry Strives for Unity Amidst Controversies, Emphasizing Equity and Responsible Practices

Psychedelics Industry Strives for Unity Amidst Controversies, Emphasizing Equity and Responsible Practices
Psychedelics Industry Strives for Unity Amidst Controversies, Emphasizing Equity and Responsible Practices


The burgeoning psychedelics industry is a realm where opportunities for healing, personal growth, and societal transformation converge. As this industry takes its initial steps, it faces a crucial challenge: ensuring the establishment of robust standards, promoting diversity and inclusion, and fostering unity among its stakeholders. In this opinion piece, we will shed light on the current state of the industry: setting standards for safety and harm reduction, advocating for equity and inclusion, and addressing the battle lines that threaten unity.



Setting Standards for Safety and Harm Reduction



Oakland Bliss, a pioneering psychedelic company, has emerged as a standard-bearer for safety and harm reduction in the industry. By implementing consistent lab testing, tracking batch and lot numbers, and introducing a Universal Product Code (UPC), Oakland Bliss sets an example for others to follow. The company's commitment to harm reduction resonates deeply with its mission, ensuring safe and unadulterated psychedelic experiences for all. Furthermore, their partnerships with veterans, exemplified by the compassionate program, exhibit a commendable dedication to helping those suffering from PTSD.

Oakland Bliss's focus on community engagement and social responsibility also sets it apart. By participating in charitable initiatives and neighborhood cleanups, the company showcases its commitment to giving back to the community. This ethos has garnered endorsements from influential social media stars like Danii Banks and Kazumi, who recognize and appreciate the company's genuine care for its customers and the broader community.

Equity and Inclusion: Learning from Past Mistakes



Recognizing the lack of diversity in the cannabis industry, Oakland Bliss is determined to avoid replicating these systemic issues within the psychedelics space. The nascent industry already exhibits signs of underrepresentation, with minority ownership and women's ownership decreasing over time. By actively seeking diversity and inclusivity, Oakland Bliss aims to create an equitable and accessible psychedelic industry. The company understands that incorporating diverse voices and perspectives not only aligns with moral imperatives but also acts as a competitive advantage, fostering innovation and understanding.

Acknowledging the historical use of psychedelics in indigenous cultures, Oakland Bliss recognizes the importance of supporting and highlighting marginalized communities. By actively including underrepresented groups, the company aims to reshape the narrative around psychedelic medicine, ensuring its accessibility to those who seek its healing potential. Oakland Bliss intends to learn from past mistakes, focusing on mentorship programs and partnerships with organizations that champion equity and inclusion.

Unity in the Face of Fragmentation



The growing rift within the psychedelic community is a matter of concern. Recent controversies, such as the purported banning of critics from a psychedelic conference, have highlighted the division between grassroots legacy practitioners and corporate interests. However, it is essential to find common ground and work towards a united front that promotes the industry's core values.

While the corporate influx raises valid concerns regarding the potential exploitation of psychedelic medicine, some argue that regulation and oversight can mitigate these risks. Balancing the influx of capital with the needs of accessibility and fair distribution becomes imperative. By engaging in constructive dialogue and addressing issues such as patenting psychedelic compounds, the industry can strive for equitable practices that benefit both private interests and public welfare.



Striking a Balance: Psychedelics as Tools for Change



As the psychedelics industry evolves, it is crucial to maintain a balanced perspective on the potential of these substances. While psychedelics hold remarkable promise, they are not "magic bullets" for physical or mental health. Recognizing their role as tools for change, rather than the change itself, allows for a more nuanced understanding of their capabilities and limitations. This perspective helps ensure responsible usage and avoids oversimplification or undue hype.

The psychedelics industry stands at a critical juncture, with the power to transform healthcare, personal growth, and societal norms. Upholding safety standards, promoting equity and inclusion, and fostering unity are essential for its success. Oakland Bliss serves as an inspiring example, guiding us towards a future where psychedelics thrive while prioritizing well-being, inclusivity, and transformative potential. Let us actively engage in shaping this industry's future to create an environment that benefits all.

Join the Discussion

Recommended Stories

Real Time Analytics